Chlorpromazine versus lithium for people with schizophrenia

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To investigate the effects of chlorpromazine alone versus lithium alone in the treatment of schizophrenia, schizophrenia-like psychoses and schizoaffective psychoses. It is expected that the implementation of several subgroup analyses may be possible (see Subgroup analysis and investigation of heterogeneity).